JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online May 15, 2008, 10.2967/jnumed.107.049387
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.107.049387v1
49/6/915    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolak, A.
Right arrow Articles by Germano, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolak, A.
Right arrow Articles by Germano, G.
Journal of Nuclear Medicine Vol. 49 No. 6 915-922
© 2008 by Society of Nuclear Medicine

doi: 10.2967/jnumed.107.049387

Clinical Investigation

Quantitative Diagnostic Performance of Myocardial Perfusion SPECT with Attenuation Correction in Women

Arik Wolak1,2, Piotr J. Slomka1–3, Mathews B. Fish4, Santiago Lorenzo5, Daniel S. Berman1–3 and Guido Germano1–3

1 Department of Imaging, Cedars-Sinai Medical Center, Los Angeles, California; 2 Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California; 3 Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California; 4 Oregon Heart and Vascular Institute, Sacred Heart Medical Center, Eugene, Oregon; and 5 Department of Human Physiology, University of Oregon, Eugene, Oregon

Correspondence: For correspondence or reprints contact: Piotr J. Slomka, Cedars-Sinai Medical Center, Room A047, 8700 Beverly Blvd., Los Angeles, CA 90048. E-mail: slomkap{at}cshs.org

Attenuation correction (AC) for myocardial perfusion SPECT (MPS) had not been evaluated separately in women despite specific considerations in this group because of breast photon attenuation. We aimed to evaluate the performance of AC in women by using automated quantitative analysis of MPS to avoid any bias. Methods: Consecutive female patients—134 with a low likelihood (LLk) of coronary artery disease (CAD) and 114 with coronary angiography performed within less than 3 mo of MPS—who were referred for rest–stress electrocardiography-gated 99mTc-sestamibi MPS with AC were considered. Imaging data were evaluated for contour quality control. An additional 50 LLk studies in women were used to create equivalent normal limits for studies with AC and with no correction (NC). An experienced technologist unaware of the angiography and other results performed the contour quality control. All other processing was performed in a fully automated manner. Quantitative analysis was performed with the Cedars-Sinai myocardial perfusion analysis package. All automated segmental analyses were performed with the 17-segment, 5-point American Heart Association model. Summed stress scores (SSS) of ≥3 were considered abnormal. Results: CAD (≥70% stenosis) was present in 69 of 114 patients (60%). The normalcy rates were 93% for both NC and AC studies. The SSS for patients with CAD and without CAD for NC versus AC were 10.0 ± 9.0 (mean ± SD) versus 10.2 ± 8.5 and 1.6 ± 2.3 versus 1.8 ± 2.5, respectively; P was not significant (NS) for all comparisons of NC versus AC. The SSS for LLk patients for NC versus AC were 0.51 ± 1.0 versus 0.6 ± 1.1, respectively; P was NS. The specificity for both NC and AC was 73%. The sensitivities for NC and AC were 80% and 81%, respectively, and the accuracies for NC and AC were 77% and 78%, respectively; P was NS for both comparisons. Conclusion: There are no significant diagnostic differences between automated quantitative MPS analyses performed in studies processed with and without AC in women.

Key Words: attenuation correction • myocardial perfusion • quantification • women • gender

COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2008 49: 13A-14A. [Full Text]  



This article has been cited by other articles:


Home page
JNMHome page
M. Prasad, P. J. Slomka, M. Fish, P. Kavanagh, J. Gerlach, S. Hayes, D. S. Berman, and G. Germano
Improved Quantification and Normal Limits for Myocardial Perfusion Stress-Rest Change
J. Nucl. Med., February 1, 2010; 51(2): 204 - 209.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. A. Kennedy, O. Israel, and A. Frenkel
Directions and Magnitudes of Misregistration of CT Attenuation-Corrected Myocardial Perfusion Studies: Incidence, Impact on Image Quality, and Guidance for Reregistration
J. Nucl. Med., September 1, 2009; 50(9): 1471 - 1478.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2008 by the Society of Nuclear Medicine.